The ethyl acetate extract showed pronounced inhibitory properties against butyrylcholinesterase, highlighting the possibility for a new, efficient Alzheimer’s disease therapeutic agent. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.